Corient Private Wealth’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $214K | Buy |
12,530
+5,371
| +75% | +$91.8K | ﹤0.01% | 2284 |
|
|
2025
Q1 | $457K | Buy |
7,159
+691
| +11% | +$44.1K | ﹤0.01% | 1637 |
|
|
2024
Q4 | $786K | Buy |
+6,468
| New | +$786K | ﹤0.01% | 1420 |
|
|
2024
Q3 | – | Sell |
-7,828
| Closed | -$1.24M | – | 2512 |
|
|
2024
Q2 | $1.24M | Buy |
7,828
+1,347
| +21% | +$213K | ﹤0.01% | 1241 |
|
|
2024
Q1 | $839K | Buy |
6,481
+492
| +8% | +$63.7K | ﹤0.01% | 1369 |
|
|
2023
Q4 | $578K | Buy |
5,989
+1,941
| +48% | +$187K | ﹤0.01% | 1536 |
|
|
2023
Q3 | $491K | Buy |
+4,048
| New | +$491K | ﹤0.01% | 1506 |
|
|
2023
Q1 | – | Sell |
-3,934
| Closed | -$510K | – | 2029 |
|
|
2022
Q4 | $510K | Buy |
+3,934
| New | +$510K | ﹤0.01% | 1135 |
|